Lysosomal Disease Summit Draws Global Participation Ahead of October 2025 Meeting in Sydney
New Submissions Span Five Continents, Reflecting Expanding International Reach
Sydney, Australia | June 2025 – The 3rd Annual Lysosomal Disease Summit, to be held 24–26 October 2025 at the Hyatt Regency Sydney, is seeing record global engagement. Researchers and practitioners from across five continents—including first-time representation from Iran, Kazakhstan, Pakistan, Spain, and the United Kingdom—have joined the programme through abstract submissions, signaling growing worldwide momentum in lysosomal disease research and care.
Designed for clinicians, researchers, policy makers, and health system stakeholders, the 2025 Summit offers a programme built to translate emerging evidence into meaningful advances in diagnosis, treatment, and collaboration.
“Innovation begins with connection,” said Professor Maria Fuller, BAppSc, MAppSc, PhD, FFSc(RCPA), a 2025 Lysosomal Disease Summit Course Director. “This year’s Summit will bring together pioneering minds to explore cutting-edge research and ignite collaborations that shape the future of lysosomal diseases. Every contribution helps drive discovery forward and creates opportunities to improve patient care meaningfully.”
Programme Highlights
- Groundbreaking research presentations from international and APAC-based experts
- Strategic panel discussions on current challenges and treatment developments
- Dedicated sessions to support early-career researchers
- Networking and collaboration opportunities with global and regional stakeholders
Attendees will engage with leading voices in lysosomal disease research and treatment, explore diagnostic innovations, and build new partnerships across industry, academia, and clinical care.
Registration is now open. For details on the programme, sponsorship, or how to attend, visit lysosomaldiseasesummit.org.
About the Lysosomal Disease Summit
The Lysosomal Disease Summit, a collaborative effort with Fabry Australia and independently managed by Etherio, is a premier scientific event dedicated to advancing research, collaboration, and innovation in lysosomal disease treatment. Now in its third year, the Summit serves as a vital forum for experts across the APAC region to share knowledge and drive progress in the field.